Skip to content

Performance of bioresorbarble scaffold in primary percutaneous intervention of ST elevation myocardial infarct

Performance of bioresorbarble scaffold in primary percutaneous intervention of ST elevation myocardial infarct - BVS in STEMI

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43286
Enrollment
10
Registered
2016-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disase. myocardial infarction

Interventions

Randomization between Xience metallic stent and bioresorbable scaffold

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) History of chest pain 18 years 5) Oral informed consent

Exclusion criteria

Exclusion criteria: 1) Contraindications to long term DAPT 2) Known kidney failure with GFR 2,5 mm) at culprit lesion. 2) TIMI 0-1 flow after aspiration 3) Unable to advance thrombus aspiration catheter

Design outcomes

Primary

MeasureTime frame
Minimum flow area by OCT after 12 months

Secondary

MeasureTime frame
OCT endpoints 1. Area stenosis 2. Lumen late loss 3. Crushed stent segments 4. Malapposition of stent struts 5. Minimum expansion of the stents expressed as absolute area and percentage of the closest reference area, 6. Vessel ostial stent area (acute and at FU) 7. Thrombus burden Angiographic endpoints 1.TIMI flow pre and post PCI, 2.Blush grade 3.Thrombus burden 4. Angiographic complications 5. Contrast use 6. Procedure time 7. Radiation skin dose Clinical endpoints Index admission: 1. Total death 2. Cardiac death 3. Non-index procedure myocardial infarction 4. Stent thrombosis (definite and probable) 5. TLR and TVR 6. non-TVR Follow up: 1. Total death 2. Cardiac death 3. Non-index procedure myocardial infarction 4. Stent thrombosis (definite and probarble) 5. TLR and TVR 6. non-TVR 7. CCS angina class 8. Vascular cerebral events 9. Admissions for congestive heart failure or arrhythmia

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)